The article describes impact of advanced research in the USA and collaborative approach of US scientists and clinicians on development of the field of islet transplantation in Poland and all over the world. At the same time, it presents negative consequences of islet regulation by FDA as a biological drug leading to decline and extinction of the field in the US, while it is on the rise worldwide.
To cite this article
Islet Transplantation – perspective from Poland
Submission date: 24 Oct 2019
Revised on: 28 Oct 2019
Accepted on: 04 Nov 2019
Published online: 08 Nov 2019
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.